|
1
|
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.
|
J Med Chem
|
2003
|
1.03
|
|
2
|
Laser-fabricated porous alumina membranes for the preparation of metal nanodot arrays.
|
Small
|
2008
|
1.00
|
|
3
|
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
|
J Biol Chem
|
2007
|
0.92
|
|
4
|
In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
|
Mol Pharmacol
|
2008
|
0.86
|
|
5
|
Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding.
|
Bioorg Med Chem Lett
|
2002
|
0.81
|
|
6
|
Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction.
|
Am J Vet Res
|
2002
|
0.80
|
|
7
|
Highly active PtAu alloy nanoparticle catalysts for the reduction of 4-nitrophenol.
|
Nanoscale
|
2013
|
0.79
|
|
8
|
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.
|
Bioorg Med Chem Lett
|
2010
|
0.79
|
|
9
|
Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
|
Bioorg Med Chem Lett
|
2008
|
0.79
|
|
10
|
Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore.
|
Bioorg Med Chem Lett
|
2010
|
0.77
|
|
11
|
Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment.
|
Bioorg Med Chem Lett
|
2010
|
0.77
|
|
12
|
The variable origin of the lateral circumflex femoral artery: a meta-analysis and proposal for a new classification system.
|
Folia Morphol (Warsz)
|
2016
|
0.75
|